Atlas Trials

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis

Clinical trial NCT04470154 · COMPLETED

Trial details

NCT number
NCT04470154
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Uremic Pruritus
Start date
2020-08-10
Primary completion
2021-10-28
Enrollment
131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.